These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7299119)
1. In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus. Yarchoan R; Murphy BR; Strober W; Clements ML; Nelson DL J Immunol; 1981 Nov; 127(5):1958-63. PubMed ID: 7299119 [TBL] [Abstract][Full Text] [Related]
2. Human peripheral blood mononuclear cells produce IgA anti-influenza virus antibody in a secondary in vitro antibody response. Yarchoan R; Barrow LA; Kurman C; Strober W; Nelson DL J Immunol; 1985 Aug; 135(2):1033-9. PubMed ID: 3874224 [TBL] [Abstract][Full Text] [Related]
3. Specific anti-influenza virus antibody production in vitro by human peripheral blood mononuclear cells. Yarchoan R; Murphy BR; Strober W; Schneider HS; Nelson DL J Immunol; 1981 Dec; 127(6):2588-94. PubMed ID: 6975330 [TBL] [Abstract][Full Text] [Related]
4. Defective in vitro antibody production in response to pokeweed mitogen and influenza antigen in patients with Hodgkin's disease. Sigfusson A; Babbage JW; Souhami RL Clin Exp Immunol; 1985 May; 60(2):396-402. PubMed ID: 4006304 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of specific anti-influenza antibody production by cultured lymphocytes from patients with systemic lupus erythematosus following influenza immunization. Mitchell DM; Fitzharris P; Knight RA; Schild GC; Snaith ML Clin Exp Immunol; 1982 Aug; 49(2):290-6. PubMed ID: 7127906 [TBL] [Abstract][Full Text] [Related]
6. Marked in vitro spontaneous secretion of IgA by human rib bone marrow mononuclear cells. Alley CD; Nash GS; MacDermott RP J Immunol; 1982 Jun; 128(6):2604-8. PubMed ID: 7200501 [TBL] [Abstract][Full Text] [Related]
7. Live tissue culture influenza vaccine for oral administration. I. Specific immune response to monovaccine A (H3N2) in volunteers. Alekseeva AK; Andzhaparidze OG; Gracheva EN; Sidorova LA; Melnikova SK Acta Virol; 1979 Jan; 23(1):59-66. PubMed ID: 35960 [TBL] [Abstract][Full Text] [Related]
8. PPD-induced viral antibody production in human blood lymphocytes. Biberfeld G; Forsgren M; Von Stedingk LV; Arneborn P Clin Exp Immunol; 1980 Nov; 42(2):364-9. PubMed ID: 7471516 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of specific in vitro antibody production following influenza immunization. Mitchell DM; Fitzharris P; Knight RA; Schild GC Clin Exp Immunol; 1982 May; 48(2):491-8. PubMed ID: 7105493 [TBL] [Abstract][Full Text] [Related]
10. Specific and non-specific B cell activation in measles and varicella. Arneborn P; Biberfeld G; Forsgren M; von Stedingk LV Clin Exp Immunol; 1983 Jan; 51(1):165-72. PubMed ID: 6299636 [TBL] [Abstract][Full Text] [Related]
11. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children. Edwards KM; Snyder P; Thompson JM; Johnson PR; Wright PF Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451 [TBL] [Abstract][Full Text] [Related]
12. Kinetic immunochemical studies of IgG production during local and systemic anti-influenza immune response in rats. Kovatchev D; Karaivanova L; Bochnakova E J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):323-8. PubMed ID: 2273250 [TBL] [Abstract][Full Text] [Related]
13. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703 [TBL] [Abstract][Full Text] [Related]
14. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related]
16. Specificity of in vitro anti-influenza virus antibody production by human lymphocytes: analysis of original antigenic sin by limiting dilution cultures. Yarchoan R; Nelson DL J Immunol; 1984 Feb; 132(2):928-35. PubMed ID: 6606679 [TBL] [Abstract][Full Text] [Related]
17. [Circulating and secretory antibodies in mice after administration of influenza virus by various routes]. WilczyĆski J; Loza-Tulimowska M; Semkow R Med Dosw Mikrobiol; 1979; 31(4):239-44. PubMed ID: 544981 [No Abstract] [Full Text] [Related]
18. Corticosteroid enhancement of immunoglobulin synthesis by pokeweed mitogen-stimulated human lymphocytes. Cooper DA; Duckett M; Petts V; Penny R Clin Exp Immunol; 1979 Jul; 37(1):145-51. PubMed ID: 487651 [TBL] [Abstract][Full Text] [Related]
19. Non-specific polyclonal antibody response induced by Mycoplasma pneumoniae. Biberfeld G; Arneborn P; Forsgren M; von Stedingk LV; Blomqvist S Yale J Biol Med; 1983; 56(5-6):639-42. PubMed ID: 6433575 [TBL] [Abstract][Full Text] [Related]
20. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine. Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]